Huang Zhiqing, Li Kaisi, Zhang Yue, Wu Jiaying, Liu Qiwen, Ni Zixuan, Sun Yan, Zheng Beihong
Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, China.
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Medicine (Baltimore). 2025 Jun 27;104(26):e42543. doi: 10.1097/MD.0000000000042543.
Detection of low-abundance gene mutations or minority alleles in clinical samples is important and challenging in fields of tumor, infectious diseases, noninvasive prenatal diagnosis, and forensic science. The key to solving this problem is the selective enrichment of the low-abundance gene fragments. In this study, a combined polymerase and ligase chain reaction system based on conventional polymerase chain reaction was developed for the first time by introducing a heat-resistant DNA ligase and a pair of ligation primers that target the mutant site. Three EGFR gene mutations (L747_S752 del, G719A, and T790M) were used as the target mutations. Both artificial mixed samples containing 1% of 1 of the 3 EGFR gene mutations and tumor samples were used to evaluate the feasibility of the proposed new method. Sanger sequencing results showed the coexistence of the wild-type and mutant alleles when the amplification product was obtained by the combined polymerase and ligase chain reaction. The novel method based on the combined polymerase and ligase chain reaction has good performance in the detection of the 2 EGFR mutations, as the commercial kit. The novel method could be used to effectively inhibit the amplification of the wild-type gene fragment in the sample and selectively amplify the low-abundance gene fragment with a mutant site, allowing the mutation to be subsequently detected more effectively, accurately, and reliably. By using this novel method, the mutant gene present at an initial content as low as 1% could be effectively amplified and accurately detected.
在肿瘤、传染病、无创产前诊断和法医学等领域,检测临床样本中的低丰度基因突变或少数等位基因既重要又具有挑战性。解决这一问题的关键在于选择性富集低丰度基因片段。在本研究中,首次通过引入耐热DNA连接酶和一对靶向突变位点的连接引物,开发了一种基于常规聚合酶链反应的聚合酶和连接酶联合链反应系统。三种表皮生长因子受体(EGFR)基因突变(L747_S752缺失、G719A和T790M)被用作目标突变。含有三种EGFR基因突变中1%的人工混合样本和肿瘤样本均用于评估所提出新方法的可行性。桑格测序结果显示,当通过聚合酶和连接酶联合链反应获得扩增产物时,野生型和突变型等位基因共存。基于聚合酶和连接酶联合链反应的新方法在检测两种EGFR基因突变方面具有与商业试剂盒相当的良好性能。该新方法可有效抑制样本中野生型基因片段的扩增,并选择性扩增具有突变位点的低丰度基因片段,从而使后续能够更有效、准确和可靠地检测突变。通过使用这种新方法,初始含量低至1%的突变基因能够被有效扩增并准确检测。